Health and Healthcare

Tuesday's Top Biotech and Medical Stocks

From BioHealth Investor

Biotechnology

HESKA CORPORATION [HSKA] +10.67%
IDERA PHARMACEUTICAL [IDP] +8.76%
NUTRITION 21 INC [NXXI] +8.00%
METABASIS THERAPEUTI [MBRX] +5.19%
CYTORI THERAPEUTICS [CYTX] +4.76%

Diagnostic Substances

IMMUNOMEDICS INC [IMMU] +11.11%
SYNOVICS PHARMACEUTL [SYVC.OB] +6.25%
AVALON PHARMACEUTIC [AVRX] +4.93%
PRESSURE BIOSCIENC [PBIO] +4.19%
BIOMODA INC [BMOD.OB] +3.45%

Drug Delivery

COLUMBIA LABS INC [CBRX] +3.05%
NOVADEL PHARMA INC [NVD] +2.61%
SKYEPHARMA PLC [SKYE] +2.53%
BIOVAIL CORP [BVF] +2.05%
FLAMEL TECH SA ADR [FLML] +1.37%

Drug Manufacturers

PLANET TECHS INC [PLNT.OB] +29.31%
ALEXZA PHARMACEUTICA [ALXA] +5.85%
KERYX BIOPHARM INC [KERX] +5.64%
REGENERX BIOPHARM IN [RGN] +5.50%
CORTEX PHARM INC [COR] +4.62%

Medical Appliances & Equipment

MEDICAL SOLUTION MGT [MSMT.OB] +260.00%
VNUS MEDICAL TECHNOL [VNUS] +9.01%
EMERGENT GROUP INC [EMGP.OB] +6.15%
ESCALON MED CP [ESMC] +5.12%
NORTHSTAR NEUROSCI [NSTR] +5.08%

Medical Instruments & Supplies

BIOTEL INC [BTEL.OB] +19.05%
TUTOGEN MEDICAL INC [TTG] +8.33%
PROTHERICS PLC [PTIL] +3.39%
EP MEDSYSTEMS INC [EPMD] +3.25%
CHINA MEDICAL TECH [CMED] +2.42%

Medical Laboratories & Research

MEDASORB TECHNOLOGS [MSBT.OB] +7.27%
BIO-IMAGING TECH [BITI] +2.47%
PACIFIC BIOMETRICS N [PBME.OB] +0.94%
ERESEARCHTECHNOLOG [ERES] +0.79%
LABORATORY CORP NEW [LH] +0.76%

http://www.biohealthinvestor.com/

Sponsored: Want to Retire Early? Start Here

Want retirement to come a few years earlier than you’d planned? Orare you ready to retire now, but want an extra set of eyes on your finances?

Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.

Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.